社区药剂师在公共卫生突发事件中的作用：迅速应对 2019 年新型冠状病毒疫情。
Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.
机构信息
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Room, 2058, N22 Building, University of Macau, Taipa, Macao.
出版信息
Res Social Adm Pharm. 2020 Apr;16(4):583-586. doi: 10.1016/j.sapharm.2020.02.003. Epub 2020 Feb 12.
Abstract
The 2019-nCoV infection that is caused by a novel strain of coronavirus was first detected in China in the end of December 2019 and declared a public health emergency of international concern by the World Health Organization on January 30, 2020. Community pharmacists in one of the first areas that had confirmed cases of the viral infection, Macau, joined the collaborative force in supporting the local health emergency preparedness and response arrangements. This paper aimed to improve the understanding of community pharmacists' role in case of 2019-CoV outbreak based on the practical experiences in consultation with the recommendations made by the International Pharmaceutical Federation on the Coronavirus 2019-nCoV outbreak.
摘要
2019 年新型冠状病毒引发的疫情于 2019 年 12 月底在中国首次发现，并于 2020 年 1 月 30 日被世界卫生组织宣布为国际关注的突发公共卫生事件。在首个出现病毒感染确诊病例的地区之一——澳门，社区药剂师加入了协同力量，支持当地卫生应急准备和应对安排。本文旨在根据与国际药学联合会就 2019 年冠状病毒 2019-nCoV 疫情提出的建议进行咨询的实际经验，提高对社区药剂师在 2019 年冠状病毒疫情爆发时的作用的认识。
相似文献
1
Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.社区药剂师在公共卫生突发事件中的作用：迅速应对 2019 年新型冠状病毒疫情。
Res Social Adm Pharm. 2020 Apr;16(4):583-586. doi: 10.1016/j.sapharm.2020.02.003. Epub 2020 Feb 12.
2
Chinese pharmacists' rapid response to the COVID-19 outbreak.中国药剂师对新冠疫情的快速反应。
Am J Health Syst Pharm. 2020 Jul 7;77(14):1096-1097. doi: 10.1093/ajhp/zxaa120.
3
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.2019 年新型冠状病毒疫情的公共卫生初始应对和临时临床指导-美国，2019 年 12 月 31 日至 2020 年 2 月 4 日。
MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1.
4
Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.药剂师在大流行期间对患者教育的准备情况——以 SARS-CoV-2 在波兰爆发为例的横断面研究。
Int J Environ Res Public Health. 2020 Sep 12;17(18):6659. doi: 10.3390/ijerph17186659.
5
Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak.隔离、检疫、社交距离和社区管控：旧型公共卫生措施在新型冠状病毒（2019-nCoV）疫情中的关键作用。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa020.
6
Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic.社区药剂师在 COVID-19 大流行期间对疾病管理的贡献。
Prev Chronic Dis. 2020 Jul 23;17:E69. doi: 10.5888/pcd17.200317.
7
Providing pharmacy services during the coronavirus pandemic.在新冠疫情期间提供药学服务。
Int J Clin Pharm. 2020 Apr;42(2):299-304. doi: 10.1007/s11096-020-01017-0. Epub 2020 Mar 28.
8
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.突发公共卫生事件预备医疗物资供应体系面临的挑战：对中国严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）疫情爆发的反思。
Biosci Trends. 2020 Mar 16;14(1):3-8. doi: 10.5582/bst.2020.01043. Epub 2020 Feb 17.
9
An interim review of the epidemiological characteristics of 2019 novel coronavirus.2019 年新型冠状病毒的流行病学特征的中期回顾。
Epidemiol Health. 2020;42:e2020006. doi: 10.4178/epih.e2020006. Epub 2020 Feb 6.
10
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
引用本文的文献
1
Challenges, Adaptive Measures, and Opportunities of Community Pharmacy Practice in the Philippines during the COVID-19 Pandemic.菲律宾社区药房在新冠疫情期间面临的挑战、应对措施及机遇
Acta Med Philipp. 2025 Jun 30;59(8):16-26. doi: 10.47895/amp.vi0.9520. eCollection 2025.
2
Pharmaceutical Activities, Services, Medicines, and Products at Community Pharmacies in the Qassim Region of Saudi Arabia: Findings and Implications for the Future.沙特阿拉伯卡西姆地区社区药房的药学活动、服务、药品及产品：调查结果与未来启示
Cureus. 2024 Aug 27;16(8):e67957. doi: 10.7759/cureus.67957. eCollection 2024 Aug.
3
Drivers and collaborative governance of public health emergency response in the context of digital city.数字城市背景下公共卫生应急响应的驱动因素与协同治理
Front Public Health. 2024 Jul 18;12:1417490. doi: 10.3389/fpubh.2024.1417490. eCollection 2024.
4
Feasibility of pharmacy-based research opportunity to enhance community testing and surveillance.基于药房的研究机会对加强社区检测和监测的可行性。
J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102151. doi: 10.1016/j.japh.2024.102151. Epub 2024 Jun 29.
5
Occupational burnout and job satisfaction among community pharmacists.社区药剂师的职业倦怠与工作满意度
Explor Res Clin Soc Pharm. 2024 Apr 17;14:100445. doi: 10.1016/j.rcsop.2024.100445. eCollection 2024 Jun.
6
Community Pharmacy Practice During COVID-19 Pandemic: A Perspective From the Middle East.新冠疫情期间中东地区的社区药房实践：一种视角
Glob J Qual Saf Healthc. 2020 Jul 8;3(3):109-114. doi: 10.36401/JQSH-20-14. eCollection 2020 Aug.
7
Patients' Satisfaction With Pharmaceutical Care Services Provided During COVID Pandemic: Experience From Greece.新冠疫情期间患者对药学服务的满意度：来自希腊的经验
Cureus. 2023 Apr 18;15(4):e37743. doi: 10.7759/cureus.37743. eCollection 2023 Apr.
8
The impact of COVID-19 on the mental health of Lebanese pharmacists: A national cross-sectional study.COVID-19 对黎巴嫩药剂师心理健康的影响：一项全国性横断面研究。
Front Public Health. 2023 Apr 13;11:1156840. doi: 10.3389/fpubh.2023.1156840. eCollection 2023.
9
Global overview of pharmacist and community pharmacy actions to address COVID-19: A scoping review.药剂师及社区药房应对2019冠状病毒病行动的全球概述：一项范围综述
Explor Res Clin Soc Pharm. 2023 Jun;10:100261. doi: 10.1016/j.rcsop.2023.100261. Epub 2023 Apr 12.
10
The Effect of Tang Forte (Royal Jelly) Capsule on Hypoglycemia and Clinical Course in COVID-19 Patients Under Corticosteroid Therapy.唐富乐（蜂王浆）胶囊对 COVID-19 患者在皮质类固醇治疗下的低血糖症及临床病程的影响。
J Evid Based Integr Med. 2023 Jan-Dec;28:2515690X231165333. doi: 10.1177/2515690X231165333.
本文引用的文献
1
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
2
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
3
Return of the Coronavirus: 2019-nCoV.冠状病毒再现：2019-nCoV。
Viruses. 2020 Jan 24;12(2):135. doi: 10.3390/v12020135.
4
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.从沙特阿拉伯一名患有肺炎的男子中分离出一种新型冠状病毒。
N Engl J Med. 2012 Nov 8;367(19):1814-20. doi: 10.1056/NEJMoa1211721. Epub 2012 Oct 17.
5
Severe acute respiratory syndrome.严重急性呼吸综合征
Nat Med. 2004 Dec;10(12 Suppl):S88-97. doi: 10.1038/nm1143.
6
SARS: epidemiology.严重急性呼吸综合征：流行病学
Respirology. 2003 Nov;8 Suppl(Suppl 1):S9-14. doi: 10.1046/j.1440-1843.2003.00518.x.
Zotero 插件